Skip to main content

Table 2 Proportion of patients (%) and medians for health care use during 2012 by patient group

From: Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study

  Schizophrenia (%) NAP (%) RR 95% CI
Inpatient carea 25.01 29.34 0.85 0.82–0.90
Outpatient carea 84.10 76.69 1.08 1.08–1.11
Primary care 63.29 66.49 0.95 0.78–1.17
Psychiatric carea 78.64 60.04 1.31 1.28–1.33
No Psychiatric carea 21.36 39.96 0.54 0.51–0.56
  Schizophrenia (medians, range) NAP (medians, range) Wilcoxon rank sum test/χ2 statistics P-value
Primary care consultations b 2 (0–1142) 2 (0–1023) 18.51 <0.0001
Outpatient consultations b 23 (0–1303) 14 (0–2335) 319.94 <0.0001
Outpatient psychiatric consultationsb 13 (0–1123) 3 (0–226) 879.01 <0.0001
Inpatient admissions b 0 (0–93) 0 (0–45) 46.75 <0.0001
Inpatient psychiatric admissionsb 0 (0–63) 0 (0–39) 13.72 0.0002
Inpatient care, daysb 0 (0–364) 13 (1–336) 25.77 <0.0001
Inpatient psychiatric care, daysb 0 (0–364) 0 (0–337) 5.82 0.02
  1. Note: The categories ‘Inpatient care’ and ‘Outpatient care’ include somatic and psychiatric consultations. ‘Psychiatric care’ includes inpatient and outpatient psychiatric care. Psychiatric care given at the primary level of care is not included
  2. aStatistically significant difference in RR between the two diagnostic groups (95% CI for RR)
  3. bStatistically significant difference between the two diagnostic groups by Wilcoxon rank sum test/χ2 statistics